NDC properties for NDC 9 50090-6411
NDC item 50090641100
| NDC 9 | 50090-6411 |
|---|---|
| NDC 10 | 50090-6411-0 |
| NDC Item | 50090641100 |
| packaging | 1 SYRINGE in 1 CARTON (50090-6411-0) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 705859 |
| Labeler | A-S Medication Solutions |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
NDC item 55513041001
| NDC 9 | 55513-410 |
|---|---|
| NDC 10 | 55513-410-01 |
| NDC Item | 55513041001 |
| packaging | 1 SYRINGE in 1 CARTON (55513-410-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
NDC item 55513041002
| NDC 9 | 55513-410 |
|---|---|
| NDC 10 | 55513-410-02 |
| NDC Item | 55513041002 |
| packaging | 2 SYRINGE in 1 CARTON (55513-410-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 770230 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |